(Q41381139)

30 September 2017

title

Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. (English)

1 reference

30 September 2017

Jacobsen H

1

1 reference

30 September 2017

Yasargil K

2

1 reference

30 September 2017

Winslow DL

3

1 reference

30 September 2017

Craig JC

4

1 reference

30 September 2017

Kröhn A

5

1 reference

30 September 2017

Duncan IB

6

1 reference

30 September 2017

Mous J

7

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

30 September 2017

1 reference

30 September 2017

volume

206

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

527-534

1 reference

Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

PCR amplification of HIV-1 proteinase sequences directly from lab isolates allows determination of five conserved domains

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

1 reference

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

1 reference

7 January 2021

Rational design of peptide-based HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Nucleotide sequence of the AIDS virus, LAV

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Structure-based inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2895%2980069-7

7 January 2021

10.1016/S0042-6822(95)80069-7

Identifiers

DOI

1 reference

30 September 2017

1 reference